» Articles » PMID: 28671671

Wnt/β-catenin Activation and Macrophage Induction During Liver Cancer Development Following Steatosis

Overview
Journal Oncogene
Date 2017 Jul 4
PMID 28671671
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity confers an independent risk for carcinogenesis. In the liver, steatosis often proceeds cancer formation; however, the mechanisms by which steatosis promotes carcinogenesis is unknown. We hypothesize that steatosis alters the microenvironment to promote proliferation of tumor initiating cells (TICs) and carcinogenesis. We used several liver cancer models to address the mechanisms underlying the role of obesity in cancer and verified these findings in patient populations. Using bioinformatics analysis and verified by biochemical assays, we identified that hepatosteatosis resulting from either Pten deletion or transgenic expression of HCV core/NS5A proteins, promotes the activation of Wnt/β-catenin. We verified that high fat diet lipid accumulation is also capable of inducing Wnt/β-catenin. Caloric restriction inhibits hepatosteatosis, reduces Wnt/β-catenin activation and blocks the expansion of TICs leading to complete inhibition of tumorigenesis without affecting the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) loss regulated protein kinase B (AKT) activation. Pharmacological inhibition or loss of the Wnt/β-catenin signal represses TIC growth in vitro, and decreases the accumulation of TICs in vivo. In human liver cancers, ontology analysis of gene set enrichment analysis (GSEA)-defined Wnt signature genes indicates that Wnt signaling is significantly induced in tumor samples compared with healthy livers. Indeed, Wnt signature genes predict 90% of tumors in a cohort of 558 patient samples. Selective depletion of macrophages leads to reduction of Wnt and suppresses tumor development, suggesting infiltrating macrophages as a key source for steatosis-induced Wnt expression. These data established Wnt/β-catenin as a novel signal produced by infiltrating macrophages induced by steatosis that promotes growth of tumor progenitor cells, underlying the increased risk of liver tumor development in obese individuals.

Citing Articles

The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer.

Santoso A, Levink I, Pihlak R, Chau I Curr Oncol. 2025; 32(1).

PMID: 39851940 PMC: 11763487. DOI: 10.3390/curroncol32010024.


The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy.

Guo R, Wang P Breast Cancer. 2024; 32(2):227-241.

PMID: 39589625 DOI: 10.1007/s12282-024-01654-7.


SerpinB3: A Multifaceted Player in Health and Disease-Review and Future Perspectives.

Cagnin S, Pontisso P, Martini A Cancers (Basel). 2024; 16(14).

PMID: 39061218 PMC: 11274807. DOI: 10.3390/cancers16142579.


Tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for hepatocellular carcinoma: recent research progress.

Li Z, Duan D, Li L, Peng D, Ming Y, Ni R Front Pharmacol. 2024; 15:1382256.

PMID: 38957393 PMC: 11217528. DOI: 10.3389/fphar.2024.1382256.


Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target.

Zhao Z, Cui T, Wei F, Zhou Z, Sun Y, Gao C Front Oncol. 2024; 14:1367364.

PMID: 38634048 PMC: 11022604. DOI: 10.3389/fonc.2024.1367364.


References
1.
Ueda S, Kawamata M, Teratani T, Shimizu T, Tamai Y, Ogawa H . Establishment of rat embryonic stem cells and making of chimera rats. PLoS One. 2008; 3(7):e2800. PMC: 2483735. DOI: 10.1371/journal.pone.0002800. View

2.
Emami K, Nguyen C, Ma H, Kim D, Jeong K, Eguchi M . A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A. 2004; 101(34):12682-7. PMC: 515116. DOI: 10.1073/pnas.0404875101. View

3.
Calle E, Rodriguez C, Walker-Thurmond K, Thun M . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348(17):1625-38. DOI: 10.1056/NEJMoa021423. View

4.
Xu X, Kobayashi S, Qiao W, Li C, Xiao C, Radaeva S . Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest. 2006; 116(7):1843-52. PMC: 1474816. DOI: 10.1172/JCI27282. View

5.
Eckert C, Klein N, Kornek M, Lukacs-Kornek V . The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. Front Immunol. 2015; 6:179. PMC: 4403526. DOI: 10.3389/fimmu.2015.00179. View